Alzheimer's drug slowed progression of disease in late-stage study, drugmakers say - 1breakingnews.c
Officials said they will submit the new trial results to the FDA to bolster its case that lecanemab should be approved as an Alzheimer's treatment.
VIEW MORE : https://bit.ly/1breakingnews
VIEW MORE : https://bit.ly/1breakingnews
Category
🥇
Sports